Delcath Systems, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 3840 www.delcath.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems to Participate in Upcoming Investor Conferences - Nov 6th, 2025 2:01 pm
Delcath Systems (DCTH) Profitability and Margin Gains Reinforce Value Bull Case, Despite Dilution Concerns - Nov 6th, 2025 6:14 am
Should Delcath Systems' Transition to Year-to-Date Profitability Prompt a Rethink for DCTH Investors? - Nov 4th, 2025 3:08 pm
Delcath Systems Inc (DCTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 4th, 2025 2:06 pm
Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates - Nov 4th, 2025 7:15 am
Delcath Systems Reports Third Quarter 2025 Results and Business Highlights - Nov 4th, 2025 6:00 am
Time To Worry? Analysts Just Downgraded Their Delcath Systems, Inc. (NASDAQ:DCTH) Outlook - Oct 28th, 2025 4:26 am
Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. - Oct 27th, 2025 2:43 pm
Delcath Systems (DCTH): Assessing Valuation Following Promising CHOPIN Trial Results and Updated Growth Outlook - Oct 23rd, 2025 6:15 pm
Is Stronger Guidance and CHOPIN Data Changing the Investment Case for Delcath Systems (DCTH)? - Oct 21st, 2025 2:11 pm
Delcath Systems to Host Third Quarter 2025 Earnings Call - Oct 21st, 2025 6:30 am
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results - Oct 18th, 2025 2:15 pm
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint - Oct 18th, 2025 2:13 pm
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives - Oct 9th, 2025 6:55 am
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress - Sep 22nd, 2025 2:01 pm
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 5th, 2025 2:01 pm
Invesco Backs Delcath Systems (DCTH) on Expansion Potential - Sep 4th, 2025 12:52 pm
Is The Market Rewarding Delcath Systems, Inc. (NASDAQ:DCTH) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Sep 3rd, 2025 10:36 am
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - Aug 19th, 2025 6:30 am
Impressive Earnings May Not Tell The Whole Story For Delcath Systems (NASDAQ:DCTH) - Aug 14th, 2025 4:31 am